NCT06817850

Brief Summary

The study aims to determine if there is a systematic difference (bias) between pulse oximeters used in control systems for automated oxygen delivery (A-FiO2) and those used in monitoring systems. When using A-FiO2 systems there are commonly two oximeter probes on the infant with two difference readouts. Nurses report frustration that the two readings are often markedly different. It is understandable that physiological differences between sensor sites might reflect different regional oxygen saturation levels. It is also possible that there is a relevant systematic bias between difference monitors and sensors. Therefore, a large systematic multicenter study is needed to determine whether these frequent differences should be ignored as physiological noise or considered clinically relevant.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

March 15, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2025

Completed
Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

January 21, 2025

Last Update Submit

March 24, 2025

Conditions

Keywords

pulse oximetryautomated FiO2 controlSpO2

Outcome Measures

Primary Outcomes (1)

  • Bias between paired SpO2 measurements

    Bias between paired SpO2 in three ranges: 1. Hypoxemia (SpO2: 70 - \<89.5%), 2. Normoxemia (SpO2: 89.5-95.5%) 3. Hyperoxemia (SpO2: \>95.5-100%) The ranges are determined as the mean of the two oximeters.

    1 month (250 observations is expected from each participating center; on average 2 patients and 5 observations per day per patient assumed)

Secondary Outcomes (6)

  • Bias between paired SpO2 related to site

    1 month (250 observations is expected from each participating center; on average 2 patients and 5 observations per day per patient assumed)

  • Bias between paired SpO2 related to sensor location

    1 month (250 observations is expected from each participating center; on average 2 patients and 5 observations per day per patient assumed)

  • Bias between paired SpO2 related to oximeter brand pairs

    1 month (250 observations is expected from each participating center; on average 2 patients and 5 observations per day per patient assumed)

  • Bias between paired SpO2 related to sensor pairs

    1 month (250 observations is expected from each participating center; on average 2 patients and 5 observations per day per patient assumed)

  • Bias between paired SpO2 related to oximeter averaging setting

    1 month (250 observations is expected from each participating center; on average 2 patients and 5 observations per day per patient assumed)

  • +1 more secondary outcomes

Study Arms (1)

Infants in the NICU with two oximeters

Infants in the NICU monitored with two oximeters with probes in preductal locations. The use of A-FiO2 is expected.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All infants in the NICU monitored with two simultaneous oximeters with probes in preductal locations. The use of A-FiO2 is expected.

You may qualify if:

  • Observations of any infant in the neonatal ICU with two simultaneous oximeter monitors may be included. The sites' Ethics Committee must review the protocol, approve participation and determine if Informed Consent is required. If required, it might be prospective, that is prior to collecting any data, or retrospective.

You may not qualify if:

  • One oximeter monitoring post ductal SpO2 in infant with clinically relevant shunt.
  • Monitor and A-FiO2 Oximeter not reading between 70-100%
  • Less than 5 minutes between repeat Observations
  • No more than 5 measurements per day per subject with sensors in same position and same oximeters (i.e., every time either sensor is moved, 5 new Observations can be made that day).
  • Presence of motion artifact
  • Presence of sensor integrity alarms/alerts

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Motol University Hospital, Neonatal Unit

Prague, 15500, Czechia

Location

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Officials

  • Thomas E Bachman, MSc

    Czech Technical University in Prague

    PRINCIPAL INVESTIGATOR
  • Jan Janota, MD, PhD

    Motol University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jakub Rafl, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2025

First Posted

February 10, 2025

Study Start

March 15, 2025

Primary Completion

August 31, 2025

Study Completion

October 31, 2025

Last Updated

March 25, 2025

Record last verified: 2025-03

Locations